[Research Report] The plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021. The market is estimated to grow at a CAGR of 12.9 % from 2021 to 2028.
The scope of the plant-based vaccines market includes vaccine type, source, application, and geography. Based on region, the plant-based vaccines market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the plant-based vaccines market, emphasizing various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. It also includes COVID–19 impact analysis across the regions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plant-based Vaccines Market: Strategic Insights
Market Size Value in US$ 1,143.72 million in 2021 Market Size Value by US$ 2,672.05 million by 2028 Growth rate CAGR of 12.9 % from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plant-based Vaccines Market: Strategic Insights
| Market Size Value in | US$ 1,143.72 million in 2021 |
| Market Size Value by | US$ 2,672.05 million by 2028 |
| Growth rate | CAGR of 12.9 % from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Plant-Based Vaccines Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Number of Research & Development (R&D) Activities in Plant-Based Vaccines
The lack of vaccines to prevent fatal diseases has created issues and prompted a worldwide focus on the development of safer, easier, and more effective vaccines. Plants are among the world's most prolific protein creators. Plants efficiently express proteins of various complexity and glycosylation patterns. Recombinant technology is used to create plant-derived vaccines, in which the gene encoding the required antigen protein is incorporated into the plant genome. Furthermore, experts estimate that the production of a plant-based vaccine takes five to six weeks instead of the five to six months required by vaccine makers to prepare the vaccine in chicken eggs. Many countries worldwide are developing an effective vaccine to combat the spread of COVID-19, and plant-based vaccines are one of the options for vaccine development. Plant-based vaccines have a good reputation among researchers because of their well-known successful manufacturing procedure and low cost. Various research and clinical trials are carried out for the development of plant-based vaccines. For instance, Medicago Inc. a clinical-stage biotechnology company that uses plant-based technologies to develop and produce novel vaccines and antibodies had successfully produced virus-like particles (VLPs) of the novel coronavirus just 20 days after obtaining the SARS-CoV-2 gene (the virus causing the COVID-19 disease). Existing prominent players and new entrants in the plant-based vaccines market are concentrating their efforts on conducting comprehensive clinical trials to produce plant-based vaccines for a variety of therapeutic applications. Hence, the increasing number of Research & Development (R&D) activities in plant-based vaccines will surge the demand for plant-based vaccines substantially across the world, leading to an upward thrust in the market's growth.
Vaccine Type-Based Insights
Based on vaccine type, the plant-based vaccines market is segmented into bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles (VLPS), and others. The bacterial vaccines segment held the largest share of the market in 2021. However, the plant-derived virus-like particles (VLPs) segment is anticipated to register the highest CAGR of 13.6% in the market during the forecast period.
Plant-Based Vaccines Market, by Vaccine Type – 2021 & 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Source-Based Insights
Based on source, the plant-based vaccines market is segmented into tobacco plant, maize, potato, and others. The tobacco plant segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 13.3% in the market during the forecast period.
Application-Based Insights
Based on application, the plant-based vaccines market is segmented into influenza, zika virus, Ebola virus, poultry disease, COVID-19, and others. The influenza segment held the largest share of the market in 2021. However, the COVID-19 segment is anticipated to register the highest CAGR of 13.8% in the market during the forecast period.
Companies commonly adopt inorganic strategies such as mergers and acquisitions to cater to changing customer demand and maintain their brand name worldwide. Market players operating in the plant-based vaccines market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide and meet the growing demand.
By Vaccine Type
- Bacterial Vaccines
- Viral Vaccines
- Parasite Vaccines
- Plant-Derived Virus-Like Particles (VLPs)
- Others
By Source
- Tobacco Plant
- Maize
- Potato
- Others
By Application
- Influenza
- Zika Virus
- Ebola Virus
- COVID-19
- Poultry Disease
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- MEDICAGO, INC.
- British American Tobacco p.l.c.
- ICON GENETICS GMBH
- CREATIVE BIOLABS, INC.
- iBio, Inc.
- LENIOBIO
- Lumen Bioscience, Inc.
- LEAF EXPRESSION SYSTEMS LTD.
- ZYUS LIFE SCIENCES INC.
- FRAUNHOFER CMB
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type, Source, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The market is led by source tobacco plant segment is growing significantly due to the increasing use of tobacco plants in pharmaceuticals. The growing research in pharmaceutical is playing a vital role in developing new vaccines. For instance the U.S Department of Agriculture approved a plant-based vaccine for Newcastle disease that infected poultry and produced it in suspension-cultured tobacco cells.
The market is estimated to grow with a CAGR of 12.9% from 2021 to 2028.
Key factors that are driving growth of the market are increasing number of research & development (R&D) activities in plant-based vaccines and growing prevalence of infectious diseases market fuel the growth of the market.
Plant-based vaccines can be made cheaply and produced on a large scale. These vaccines have several advantages, including being readily accepted by patients and stable for long-term antigen storage. These also help to reduce the economic burden of infectious disease globally. Various plants have developed plant-derived vaccines such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut. The choice of the plant depends on the route of administration of the vaccine.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Plant-based Vaccines Market – By Vaccine Type
1.3.2 Global Plant-based Vaccines Market – By Source
1.3.3 Global Plant-based Vaccines Market – By Application
1.3.4 Global Plant-based Vaccines Market – By Geography
2. Global Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Research & Development (R&D) Activities in Plant-Based Vaccines
5.1.2 Growing Prevalence of Infectious Diseases
5.2 Market Restraints
5.2.1 Potential Risk of Contamination and Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Advancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Spur in Prevalence of Infectious Diseases and Increase in Product Approvals
5.5 Impact Analysis
6. Plant-based Vaccines Market– Global Analysis
6.1 Global Plant-based Vaccines Market Revenue Forecast and Analysis
6.2 Global Plant-based Vaccines Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. Plant-based Vaccines Market – Geographic Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Plant-Based Vaccines Market, by Source– Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Plant-based Vaccines Market
10.2.1 Overview
10.2.2 Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.4 Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.5 Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.2.6 Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.4 Germany: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.2 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.4 France: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.3 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.4 UK: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.4 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.4 Italy: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.5 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.4 Spain: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.2.6.6 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.4 Rest of Europe: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.3 Asia Pacific: Plant-based Vaccines Market
10.3.1 Overview
10.3.2 Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia Pacific: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia Pacific: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 China: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.2 Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 Japan: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.3 India: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (USD Million)
10.3.6.3.1 India: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 India: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.4 South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 South Korea: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.4 South Korea: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.5 Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 Australia: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.4 Australia: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4 South and Central America: Plant-Based Vaccines Market
10.4.1 Overview
10.4.2 South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 South and Central America Plant-Based Vaccines Market, By vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.4 South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.5 South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6 South and Central America: Plant-Based Vaccines Market Share by Country – 2021 & 2028, (%)
10.4.6.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.1.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.1.2 Brazil Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Brazil Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Brazil Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.2.1 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
10.4.6.2.2 Argentina Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 Argentina Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 Argentina Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 Rest of South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 Rest of South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.5 Middle East & Africa: Plant-based Vaccines Market
10.5.1 Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.2 Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.3 Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.4 Middle East & Africa: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.5.5 Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
10.5.5.1 Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.1.1 Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.1.2 Saudi Arabia: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.1.3 Saudi Arabia: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.1.4 Saudi Arabia: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.2 South Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (USD Million)
10.5.5.2.1 South Africa: Plant-based Vaccines Market Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.2.2 South Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.2.3 South Africa : Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.2.4 South Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.3 UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.3.1 UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.3.2 UAE: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.3.3 UAE: Plant-based Vaccines Market, by Source- Revenue and Forecast to 2028 (USD Million)
10.5.5.3.4 UAE: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.5.4 Rest of Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (USD Million)
10.5.5.4.1 Rest of Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
10.5.5.4.2 Rest of Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (USD Million)
10.5.5.4.3 Rest of Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
10.5.5.4.4 Rest of Middle East & Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ICON GENETICS GMBH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
SWOT Analysis
13.3.5 Key Developments
13.4 CREATIVE BIOLABS, INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 iBio, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 LENIOBIO
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lumen Bioscience, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 LEAF EXPRESSION SYSTEMS LTD.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ZYUS LIFE SCIENCES INC.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 FRAUNHOFER CMB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 6. US Plant-Based Vaccines Devices Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Plant-Based Vaccines Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 19. France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 20. France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 21. France: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 22. UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 23. UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 25. Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 28. Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 31. Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 34. Asia Pacific Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. China Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 38. China Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 39. China Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 40. Japan Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 41. Japan Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 42. Japan Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 43. India Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 44. India Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 45. India Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 49. Australia Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 50. Australia Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 51. Australia Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 55. South and Central America Plant-Based Vaccines Market, By vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 56. South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 57. South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 58. Brazil Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 59. Brazil Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 60. Brazil Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 61. Argentina Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 62. Argentina Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 63. Argentina Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 65. Rest of South and Central America Plant-Based Vaccines Market, By Source – Revenue and Forecast to 2028 (USD Million)
Table 66. Rest of South and Central America Plant-Based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 67. Middle East & Africa Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Middle East & Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 69. Middle East & Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 70. Saudi Arabia Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 71. Saudi Arabia Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 72. Saudi Arabia Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 73. South Africa Apnea Diagnostics Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 74. South Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 75. South Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. UAE Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 77. UAE Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 78. UAE Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of Middle East & Africa Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of Middle East & Africa Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of Middle East & Africa Plant-based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 82. Recent organic developments in the Plant-based Vaccines Market
Table 83. Glossary of Terms, plant-based vaccines devices market
LIST OF FIGURES
Figure 1. Plant-based Vaccines Market Segmentation
Figure 2. Plant-based Vaccines Market Segmentation, By Region
Figure 3. Global Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Plant-based Vaccines Market
Figure 5. Asia Pacific to Show Significant Growth during Forecast Period
Figure 6. Plant-based Vaccines Market, by Geography (US$ Million)
Figure 7. Global Plant-based Vaccines Market – Leading Country Markets (US$ Million)
Figure 8. Global Plant-based Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 15. Global Plant-based Vaccines Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Plant-based Vaccines Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Plant-based Vaccines Market
Figure 18. Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 19. Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 25. Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 30. Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 35. Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 36. North America: Plant-Based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. North America Plant-Based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 38. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 39. US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 43. Europe: Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 44. Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 45. Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Asia Pacific: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 52. Asia Pacific Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 54. China Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Japan: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. India: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South Korea: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. Rest of Asia Pacific: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. South and Central America: Plant-Based Vaccines Market, By Key Country – Revenue (2021) (USD Million)
Figure 61. South and Central America: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 62. South and Central America: Plant-Based Vaccines Market Share by Country – 2021 & 2028, (%)
Figure 63. Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 64. Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (USD Million)
Figure 65. Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. Middle East & Africa: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 67. Middle East & Africa Plant-based Vaccines Market Revenue and Forecast to 2028 (USD Million)
Figure 68. Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
Figure 69. Saudi Arabia: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 70. South Africa: Plant-based Vaccines Market Market– Revenue and Forecast to 2028 (USD Million)
Figure 71. UAE: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of Middle East & Africa: Plant-based Vaccines Market– Revenue and Forecast to 2028 (USD Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic In European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 77. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 78. Growth Strategies in the Plant-based Vaccines Market, 2019-2021
The List of Companies - Plant-based Vaccines Market
- MEDICAGO, INC.
- British American Tobacco p.l.c.
- ICON GENETICS GMBH
- CREATIVE BIOLABS, INC.
- iBio, Inc.
- LENIOBIO
- Lumen Bioscience, Inc.
- LEAF EXPRESSION SYSTEMS LTD.
- ZYUS LIFE SCIENCES INC.
- FRAUNHOFER CMB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Plant-based Vaccines Market
Nov 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)